5 GREENWAY PLAZA, HOUSTON, TX
Third Quarter 2025 Earnings Considerations
Promotes Richard A. Jackson to Senior Vice President and Chief Operating Officer
News, Reorganization Plan
To Acquire OxyChem, Investor Presentation
Announces 2nd Quarter 2025 Results
News, Legal Opinion
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
Second Quarter 2025 Earnings Considerations
Q2
Q1
FY 2023
Q3
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Registration Statement for Securities to be Offered to Employees
SC TO-I
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Annual Report of Employee Stock Purchase
Specialized Disclosure Report
Amended Tender Offer Statement by Issuer
Prospectus filed pursuant to Rule 424(b)(7)